Voloridge Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.2M | Buy |
1,022,309
+868,188
| +563% | +$47.7M | 0.21% | 125 |
|
|
2025
Q1 | $10.9M | Sell |
154,121
-117,177
| -43% | -$8.28M | 0.04% | 547 |
|
|
2024
Q4 | $17.8M | Buy |
271,298
+222,958
| +461% | +$14.7M | 0.06% | 383 |
|
|
2024
Q3 | $3.4M | Buy |
48,340
+41,867
| +647% | +$2.94M | 0.01% | 857 |
|
|
2024
Q2 | $533K | Buy |
+6,473
| New | +$533K | ﹤0.01% | 1120 |
|
|
2023
Q1 | – | Sell |
-50,336
| Closed | -$5.21M | – | 1374 |
|
|
2022
Q4 | $5.21M | Buy |
+50,336
| New | +$5.21M | 0.03% | 625 |
|
|
2022
Q1 | – | Sell |
-3,849
| Closed | -$340K | – | 1378 |
|
|
2021
Q4 | $340K | Buy |
+3,849
| New | +$340K | ﹤0.01% | 1461 |
|
|
2021
Q3 | – | Sell |
-32,017
| Closed | -$2.67M | – | 1653 |
|
|
2021
Q2 | $2.67M | Sell |
32,017
-21,510
| -40% | -$1.79M | 0.02% | 880 |
|
|
2021
Q1 | $4.04M | Buy |
+53,527
| New | +$4.04M | 0.03% | 594 |
|
|
2020
Q4 | – | Sell |
-8,148
| Closed | -$620K | – | 1323 |
|
|
2020
Q3 | $620K | Sell |
8,148
-1,237
| -13% | -$94.1K | 0.01% | 1056 |
|
|
2020
Q2 | $1.16M | Sell |
9,385
-45,752
| -83% | -$5.65M | 0.01% | 797 |
|
|
2020
Q1 | $4.66M | Buy |
+55,137
| New | +$4.66M | 0.13% | 171 |
|
|
2016
Q2 | – | Sell |
-3,763
| Closed | -$310K | – | 302 |
|
|
2016
Q1 | $310K | Buy |
+3,763
| New | +$310K | 0.01% | 288 |
|
|
2015
Q4 | – | Sell |
-51,760
| Closed | -$5.45M | – | 195 |
|
|
2015
Q3 | $5.45M | Sell |
51,760
-103,321
| -67% | -$10.9M | 0.26% | 102 |
|
|
2015
Q2 | $21.2M | Buy |
155,081
+27,418
| +21% | +$3.75M | 1.08% | 21 |
|
|
2015
Q1 | $15.9M | Buy |
+127,663
| New | +$15.9M | 0.77% | 34 |
|